Home / Zolmitriptan / Belgium
BE ATC N02CC03 · updated 2 Nov 2026
Zolmitriptan shortage in Belgium
Is there a Zolmitriptan shortage in Belgium?
Yes. As of 2 Nov 2026, 8 Zolmitriptan products are reported short in Belgium, the first since 3 May 2024. The company estimate for the return is 15 Feb 2027 (latest 5 Aug 2027). Main reason: other.
Also short in Canada, Austria, Australia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Zolmitriptan Sandoz 2.5 mg orodisp. tabl. 12 | Sandoz | 3 May 2024 | 15 Feb 2027 | Manufacturing problem Delay in production |
| BE | Zolmitriptan Sandoz 2.5 mg orodisp. tabl. 24 | Sandoz | 31 Oct 2024 | 15 Feb 2027 | Active ingredient shortage Active Substance not available |
| BE | Zolmitriptan ODIS Viatris 2.5 mg orodisp. tabl. 12 | Viatris GX | 19 May 2025 | 5 Aug 2027 | Manufacturing problem Delay in production |
| BE | Zolmitriptan ODIS Viatris 2.5 mg orodisp. tabl. 24 | Viatris GX | 4 Jul 2025 | 5 Aug 2027 | Other Other reason |
| BE | Zolmitriptan ODIS Viatris 2.5 mg orodisp. tabl. 48 | Viatris GX | 9 Jul 2025 | 5 Aug 2027 | Other Other reason |
| BE | Zolmitriptan ODIS Viatris 2.5 mg orodisp. tabl. 6 | Viatris GX | 21 Jul 2025 | 5 Aug 2027 | Other Other reason |
| BE | Zolmitriptan ODIS Viatris 5 mg orodisp. tabl. 12 | Viatris GX | 2 Jun 2026 | 5 Aug 2027 | Other Other reason |
| BE | Zolmitriptan ODIS Viatris 5 mg orodisp. tabl. 6 | Viatris GX | 20 Jul 2026 | 5 Aug 2027 | Manufacturing problem Delay in the release of the end product |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.